New study challenges description of airway inflammation in smokers and COPD patients

A new study challenges the widely accepted but oversimplified description of airway inflammation in smokers and patients with chronic obstructive pulmonary disease (COPD).

By analyzing airway wall tissue from individuals, investigators found that there are significantly fewer cells in the airway wall of smokers and mild to moderate COPD patients than in healthy controls, with a surprising decrease in some key inflammatory cells.

"Airway inflammation in COPD is a true paradox," said Dr. Sukhwinder Singh Sohal, senior author of the Respirology study.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Late-life smoking cessation can significantly extend life expectancy